Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teppei Yamaguchi

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA studyFumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA studyFumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Pageof 6